Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

ed as held for sale or exchange. This item has no cash impact on the Group.
  • An impairment loss against intangible assets of euro 32 million, mainly related to Metabolex agreement. This item has no cash impact on the Group.
  • A charge of euro 46 million reflecting an increase in the fair value of contingent considerations related to TargeGen business combination in accordance with IFRS3R.
  • A charge of euro 2 million arising from the workdown of inventories of acquired companies remeasured at fair value due to the application of purchase accounting to acquisitions. This item has no cash impact on the Group.
  • Euro 122 million of restructuring costs, mainly related to the modifications of the restructuring plan in French commercial operations.
  • A euro 510 million tax effect arising from the items listed above, comprising euro 458 million generated by the amortization charged against intangible assets and by the non recurring amortization charge on Merial assets, euro 10 million generated by the impairment loss and euro 42 million linked to the restructuring costs (see Appendix 7).
  • In "Share of profits/losses from associates," a charge of euro 7 million, net of tax, mainly relating to the amortization of intangible assets. This item have no cash impact on the Group.

  • Net debtIn the first quarter of 2011, net cash generated by operating activities after changes in working capital and before restructuring costs was euro 2,346 million (stable versus Q1 2010). This amount provided finance for capital expenditures (euro 340 million) and the acquisitions and partnerships made during the period (euro 382 million, mainly BMP Sunstone for euro 336 million). At the end of March 2011, the Group had a debt of euro 19,183 million linked to the funding of Genzyme acquisition and euro 19,199 million of cash and cash equivalents. Consequently, at the end of Ma
    '/>"/>

    SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

    Related medicine technology :

    1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
    8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
    9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
    10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
    11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW ... for operable and inoperable solid tumor cancers, announced today that ... th Annual Phacilitate Immunotherapy Forum in Washington ... will take place on January 26 at 10:30 a.m. EST ...
    (Date:1/23/2015)... , Jan. 23, 2015  Pete Rose, baseball,s all-time hits ... and arthritis pain reliever Myoflex, Ducere Pharma has announced. ... we are excited to have him on board with Myoflex," ... "He is a legendary player who is known across all ...
    (Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin ... a Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities ... update for shareholders detailing why a "YES" vote to increase ... Shareholders, As we reflect upon the 2014 fiscal ...
    Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
    ... 16, 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: ... discovers and develops new uses for previously approved drugs ... has received PTO notification of the allowance of two ... a unique class of compounds that combine elements of ...
    ... 16, 2011 Reportlinker.com announces that a ... its catalogue: X-ray Equipment ... http://www.reportlinker.com/p0683628/X-ray-Equipment---Top-5-American-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging This ... from the following American countries: United States, ...
    Cached Medicine Technology:Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases 2X-ray Equipment - Top 5 American Markets 2
    (Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
    (Date:1/22/2015)... The City of West Hollywood hosted a news ... the 42nd anniversary of the Supreme Court decision Roe v. Wade, ... years since the Roe vs. Wade decision and the fight to ... ever,” said City of West Hollywood Councilmember Abbe Land. “We need ...
    (Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ ... Alliance (PPHA). The PPHA's passion for others' well-being and ... greats, treated for obstructive sleep apnea (OSA) has propelled them ... in the valley. The most recent plans for an event ...
    (Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
    (Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
    Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
    ... Reject Oxygen Funding Reductions,which could ,Jeopardize Care, and ... Letter Draws Widespread Support Among Home Oxygen Community, ... Quality,Respiratory Care (CQRC) -- a coalition of the ... provide care and services to,approximately 650,000 chronically ill ...
    ... Answer That Question, BREA, Calif., March 5 ... site in the United States, now,helps pet owners ... are with a quick and humorous online Canine ... gauges pet owner,responses to determine their dog,s brain ...
    ... say , , WEDNESDAY, March 5 (HealthDay News) -- ... standard chemotherapy, the effective and much-touted leukemia drug, Gleevec, ... their reproductive years, imatinib (Gleevec) might damage the chances ... a case report published as a letter in the ...
    ... FRANKLIN, Tenn., March 5 Spheris, a leading global,provider ... the release of its financial results for the fourth ... its earnings release for the fourth quarter of,2007 after ... 2008, and,will host a conference call on Thursday, March ...
    ... incorporates key patient safety topics, methods of assessment,and ... Ill., March 5 American Board of,Medical Specialties ... Shield,of Illinois (BCBSIL) is offering the ABMS Patient ... as a resource to help improve,quality and safety ...
    ... Secretary of Health,Dr. Calvin B. Johnson met ... Center in Greensburg to discuss Governor Edward G.,Rendell,s ... hundreds of,thousands of uninsured adults through his "Cover ... critical to help prevent disease,successfully manage chronic diseases ...
    Cached Medicine News:Health News:Home Oxygen Community Applauds Senator Pat Roberts for Leading Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicare's Home Oxygen Benefit 2Health News:Is Your Dog a Canine-stein or a Bonehead? 2Health News:Is Your Dog a Canine-stein or a Bonehead? 3Health News:Gleevec May Disrupt Ovarian Function 2Health News:Gleevec May Disrupt Ovarian Function 3Health News:Blue Cross and Blue Shield of Illinois to Offer ABMS(R) Patient Safety Improvement Program to Network Physicians 2Health News:Blue Cross and Blue Shield of Illinois to Offer ABMS(R) Patient Safety Improvement Program to Network Physicians 3Health News:Pennsylvania Health Secretary Visits Westmoreland County to Urge Passage of Health Insurance for All Pennsylvanians 2
    ... Pro-2000CV tables allow 46 inches of ... and other procedures. The open design ... Lightweight and easy to maneuver, this ... Motorized movements include 16-inch elevating travel, ...
    ... Immunoassay Control is a ... designed to complement the ... Immunoassay Plus Controls. This ... to include more complex ...
    Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers....
    Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
    Medicine Products: